226 related articles for article (PubMed ID: 197414)
61. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
Siess W; Roth P; Weber PC
Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
[TBL] [Abstract][Full Text] [Related]
62. Rat platelets aggregate in the absence of endogenous precursors of prostaglandin endoperoxides.
Bult H; Bonta IL
Nature; 1976 Dec; 264(5585):449-51. PubMed ID: 1004576
[No Abstract] [Full Text] [Related]
63. Effect of minoxidil on platelet function and the synthesis of prostaglandins in platelets.
O'Barr TP; Swanson EW; Fitzpatrick JE; Corby DG
J Lab Clin Med; 1989 Nov; 114(5):575-8. PubMed ID: 2553835
[TBL] [Abstract][Full Text] [Related]
64. The activation of adenylate cyclase. II. The postulated presence of (A) adenylate cyclase in a phospho (inhibited) form (B) a dephospho (activated) form with a cyclic adenylate stimulated membrane protein kinase.
Constantopoulos A; Najjar VA
Biochem Biophys Res Commun; 1973 Aug; 53(3):794-9. PubMed ID: 4354448
[No Abstract] [Full Text] [Related]
65. Platelet aggregation. I. Regulation by cyclic AMP and prostaglandin E1.
Marquis NR; Vigdahl RL; Tavormina PA
Biochem Biophys Res Commun; 1969 Sep; 36(6):965-72. PubMed ID: 4310150
[TBL] [Abstract][Full Text] [Related]
66. Effect of agents that alter cyclic AMP on arachidonate-induced platelet aggregation in the dog.
Johnson GJ; Rao GH; Leis LA; White JG
Blood; 1980 May; 55(5):722-9. PubMed ID: 6244866
[No Abstract] [Full Text] [Related]
67. Prostacyclin analogs: antiaggregatory potency and enhancement of cAMP levels in human platelet rich plasma.
Dembinska-Kiec A; Rücker W; Schönhöfer PS; Gandolfi C
Thromb Haemost; 1979 Dec; 42(4):1340-3. PubMed ID: 232318
[No Abstract] [Full Text] [Related]
68. Azelastine potentiates the prostaglandin-induced increase of cyclic AMP content in human platelets and in guinea-pig alveolar macrophages.
Hatmi M; Havet N; Vargaftig BB; Bachelet M
Prostaglandins; 1992 May; 43(5):457-72. PubMed ID: 1374922
[TBL] [Abstract][Full Text] [Related]
69. Inhibition of human platelet aggregation by parathyroid hormone. Is cyclic AMP implicated?
Benigni A; Livio M; Dodesini P; Schieppati A; Panigada M; Mecca G; de Gaetano G; Remuzzi G
Am J Nephrol; 1985; 5(4):243-7. PubMed ID: 2996352
[TBL] [Abstract][Full Text] [Related]
70. Adenylate cyclase activity in normal and leukemic human leukocytes as determined by a radioimmunoassay for cyclic AMP.
Polgar P; Vera JC; Kelley PR; Rutenburg AM
Biochim Biophys Acta; 1973 Feb; 297(2):378-83. PubMed ID: 4350264
[No Abstract] [Full Text] [Related]
71. Disaggregation and reaggregation of 'irreversibly' aggregated platelets: a method for more complete evaluation of anti-platelet drugs.
Rao GH; White JG
Agents Actions; 1985 Jul; 16(5):425-34. PubMed ID: 3931443
[TBL] [Abstract][Full Text] [Related]
72. Modulation of human platelet function by prostacyclin and thromboxane A2.
Gorman RR
Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
[No Abstract] [Full Text] [Related]
73. Interaction of prostaglandins with canine gastric mucosal adenylate cyclase-cyclic AMP system.
Dozois RR; Kim JK; Dousa TP
Am J Physiol; 1978 Nov; 235(5):E546-51. PubMed ID: 215037
[No Abstract] [Full Text] [Related]
74. Some biochemical activities of 10,10-difluoro-13-dehydroprostacyclin, a chemically stable analog of prostacyclin, in human blood platelets.
Harris DN; Phillips MB; Michel IM; Goldenberg HJ; Haslanger MF; Antonaccio MJ; Fried J
Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):387-99. PubMed ID: 6275567
[No Abstract] [Full Text] [Related]
75. Effects of prostaglandin E2 on human platelet adenyl cyclase and aggregation.
Bruno JJ; Taylor LA; Droller MJ
Nature; 1974 Oct; 251(5477):721-3. PubMed ID: 4427671
[No Abstract] [Full Text] [Related]
76. Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid.
Vargaftig BB; Chignard M
Agents Actions; 1975 May; 5(2):137-44. PubMed ID: 51579
[TBL] [Abstract][Full Text] [Related]
77. Platelets of pseudohypoparathyroid patients: evidence that distinct receptor-cyclase coupling proteins mediate stimulation and inhibition of adenylate cyclase.
Motulsky HJ; Hughes RJ; Brickman AS; Farfel Z; Bourne HR; Insel PA
Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4193-7. PubMed ID: 6287473
[TBL] [Abstract][Full Text] [Related]
78. A cross-sectional study of platelet cyclic AMP in healthy and hypertensive pregnant women.
Horn EH; Cooper J; Hardy E; Heptinstall S; Rubin PC
Clin Sci (Lond); 1991 Jun; 80(6):549-58. PubMed ID: 1711945
[TBL] [Abstract][Full Text] [Related]
79. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
Smith JB; Ingerman CM; Silver MJ
J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
[TBL] [Abstract][Full Text] [Related]
80. Evidence for mediation of acetyl glyceryl ether phosphorylcholine stimulation of adenosine 3',5'-(cyclic)monophosphate levels in human polymorphonuclear leukocytes by leukotriene B4.
Hopkins NK; Lin AH; Gorman RR
Biochim Biophys Acta; 1983 Oct; 763(3):276-83. PubMed ID: 6313071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
